Search reports, ask a question, or jump to a page.
The problem
Intervention: Stratified immunization strategy: standard DTaP vaccination schedule for general population versus delayed DTaP for high-risk infants
Who it was tested with: 564 children with infantile epileptic spasms followed from infancy (median onset 5 months) into school age (6.5-10.5 year follow-up).
The same group is measured before the intervention and again afterwards, with a baseline and an endline and sometimes a midline. Change is visible, but other causes cannot be ruled out.
"Multivariable logistic regression in an etiologically analytic cohort (n = 541) identified the DTaP primary series as a significant independent precipitant for rapid onset (Dose 1: OR = 4.00; Doses 2 & 3: OR = 4.67)" combined with "no significant differences in all-cause mortality, seizure remission, or educational placement (p > .05) between groups, indicating that vaccination merely precipitated disease onset without altering the etiology-determined prognosis." This indicates DTaP can trigger earlier symptom appearance in susceptible infants but does not change underlying disease trajectory or outcomes.
Retrospective design limits causal inference; study cannot identify high-risk infants before vaccination; focuses on children who developed IESS without comparison to vaccinated children who did not develop seizures; lacks information on potential confounding factors
Across countries and designs
1 study · 0 countries
